Jerrold Sendrow
Plus aucun poste en cours
Fortune : 465 $ au 30/06/2024
Profil
Mr. Jerrold Sendrow was previously employed as an Independent Director by Virpax Pharmaceuticals, Inc., an Accountant-Audit Departments by Peat Marwick Mitchell & Co., a Head-Accountant by Touche Ross & Co., and an Accountant-Audit Departments by Touche Ross & Co. (Australia).
He also served on the board at Scilex Pharmaceuticals, Inc. He received his undergraduate degree from Adelphi University and an undergraduate degree from Baruch College.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 03/06/2024 | 900 ( 0,03% ) | 465 $ | 30/06/2024 |
Anciens postes connus de Jerrold Sendrow
| Sociétés | Poste | Fin |
|---|---|---|
| VIRPAX PHARMACEUTICALS, INC. | Directeur/Membre du Conseil | 05/07/2024 |
SCILEX Pharmaceuticals, Inc.
 SCILEX Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology SCILEX Pharmaceuticals, Inc. engages in the development and commercialization of pharmaceutical products. It acquires late-stage clinical development and sales and marketing of generic and branded generic products. Its product includes ZTlido. The company was founded by Anthony P. Mack and William Pedranti in 2011 and is headquartered in Berwyn, PA. | Directeur/Membre du Conseil | 01/11/2016 |
| Touche Ross & Co. | Comptroller/Controller/Auditor | - |
| Touche Ross & Co. (Australia) | Comptroller/Controller/Auditor | - |
| Peat Marwick Mitchell & Co. | Comptroller/Controller/Auditor | - |
Formation de Jerrold Sendrow
| Baruch College | Undergraduate Degree |
| Adelphi University | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| VIRPAX PHARMACEUTICALS, INC. | Health Technology |
| Entreprise privées | 4 |
|---|---|
SCILEX Pharmaceuticals, Inc.
SCILEX Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology SCILEX Pharmaceuticals, Inc. engages in the development and commercialization of pharmaceutical products. It acquires late-stage clinical development and sales and marketing of generic and branded generic products. Its product includes ZTlido. The company was founded by Anthony P. Mack and William Pedranti in 2011 and is headquartered in Berwyn, PA. | Health Technology |
| Peat Marwick Mitchell & Co. | Commercial Services |
| Touche Ross & Co. (Australia) | |
| Touche Ross & Co. | Commercial Services |
